Clearside Biomedical, Inc.
Clearside Biomedical, Inc. (CLSD) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001539029 · CLSD · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001539029 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Clearside Biomedical, Inc. (NASDAQ: CLSD) has submitted 552 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2016. As a Healthcare sector company with CIK 0001539029, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Clearside Biomedical, Inc.'s most comprehensive regulatory disclosure. The most recent Clearside Biomedical, Inc. 10-K was filed on 2025-03-27 for fiscal year ending 2025. Historical CLSD 10-K annual reports are available from 2012 through 2025.
Investors researching Clearside Biomedical, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CLSD SEC Filings · 8 questionsClearside Biomedical, Inc. (CLSD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 552 filings and access original documents at no cost. Clearside Biomedical, Inc.'s CIK is 0001539029.